
|Videos|October 11, 2016
Measuring Outcomes in Atopic Dermatitis
Advertisement
Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Cheryl Allen, BS Pharm, MBA; and Jeffrey D. Dunn, PharmD, MBA, discuss the safety and selection of long-term treatments in atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
Pharmacy Policy Updates for October 2025
3
UConn’s Medical Writing Certificate Program: It’s Just "Write"
4
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
5